I Nakao

1.2k total citations
32 papers, 895 citations indexed

About

I Nakao is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I Nakao has authored 32 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I Nakao's work include Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer therapeutics and mechanisms (6 papers). I Nakao is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer therapeutics and mechanisms (6 papers). I Nakao collaborates with scholars based in Japan, Pakistan and United States. I Nakao's co-authors include A Wakui, Y. Shimada, Makoto Yoshino, K Futatsuki, Tetsuya Taguchi, N. Ogawa, Yasushi Sakata, Nami Ogawa, Yuh Sakata and T Taguchi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Graefe s Archive for Clinical and Experimental Ophthalmology.

In The Last Decade

I Nakao

28 papers receiving 850 citations

Peers

I Nakao

ONCOL

PRM

SURGE

Minoru Niimoto Japan

H Egami Japan

Yoshihito Gomyo Japan

Toshiyuki Tenjo Japan

Yoshihiro Nakazato Japan

Chang‐Chieh Wu Taiwan

Chau P. Tran United States

Helen P. Meijer Netherlands

Jun Ye China

Xiaojuan Wu China

Minoru Niimoto Japan

I Nakao

415 ×0.7

ONCOL

296 ×0.7

274 ×1.0

PRM

191 ×1.2

SURGE

122 ×1.8

Citations per year, relative to I Nakao I Nakao (= 1×) peers Minoru Niimoto

Countries citing papers authored by I Nakao

Since Specialization

Citations

This map shows the geographic impact of I Nakao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Nakao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Nakao more than expected).

Fields of papers citing papers by I Nakao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Nakao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Nakao. The network helps show where I Nakao may publish in the future.

Co-authorship network of co-authors of I Nakao

This figure shows the co-authorship network connecting the top 25 collaborators of I Nakao. A scholar is included among the top collaborators of I Nakao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Nakao. I Nakao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Enaida, Hiroshi, I Nakao, Shinichiro Ishikawa, Yuji Oshima, & Tatsuro Ishibashi. (2020). Optical coherence tomography imaging for gas-induced posterior subcapsular cataract after lens-sparing vitrectomy. Canadian Journal of Ophthalmology. 55(5). e178–e180. 1 indexed citations

Nakao, I, et al.. (2019). Observation of Schlemm’s canal and transluminal trabeculotomy using an ophthalmic endoscope: a case report. Journal of Medical Case Reports. 13(1). 249–249. 1 indexed citations

Aoki, Shigehisa, et al.. (2019). Mesenchymal cells and fluid flow stimulation synergistically regulate the kinetics of corneal epithelial cells at the air–liquid interface. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(9). 1915–1924. 7 indexed citations

Sakata, Yasuhisa, et al.. (2003). Inhibitory Mechanism of a Cross-class Serpin, the Squamous Cell Carcinoma Antigen 1. Journal of Biological Chemistry. 278(46). 45296–45304. 36 indexed citations

Nambu, Hiroyuki, H Senzaki, I Nakao, et al.. (1997). N-methyl-N-nitrosourea-induced photoreceptor apoptosis in the mouse retina.. PubMed. 10(5). 483–8. 63 indexed citations

Taguchi, Tetsuya, Kiyoyuki Furuse, M. Fukuoka, et al.. (1996). [LY188011 phase I study. Research Group of Gemcitabine (LY188011)].. PubMed. 23(8). 1011–8. 5 indexed citations

Kubota, Tetsuro, Nobuaki Sasano, Osahiko Abe, et al.. (1995). Potential of the histoculture drug-response assay to contribute to cancer patient survival.. PubMed. 1(12). 1537–43. 128 indexed citations

Sakata, Yuh, Y. Shimada, Makoto Yoshino, et al.. (1994). [A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].. PubMed. 21(7). 1039–46. 31 indexed citations

Futatsuki, K, A Wakui, I Nakao, et al.. (1994). [Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].. PubMed. 21(7). 1033–8. 154 indexed citations

10.

Taguchi, Tetsuya, Yutaka Yoshida, Tomoya Ishida, et al.. (1994). [An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with advanced breast cancer].. PubMed. 21(1). 83–90. 12 indexed citations

11.

Taguchi, Junichi, et al.. (1993). Rho(D)-positive platelet transfusions to Rho(D) negative patients. Questionnaire survey to Red Cross blood centers and clinical doctors.. Journal of the Japan Society of Blood Transfusion. 39(5). 872–876. 1 indexed citations

12.

Shimada, Y., Makoto Yoshino, A Wakui, et al.. (1993). Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.. Journal of Clinical Oncology. 11(5). 909–913. 340 indexed citations

13.

Taguchi, Takao, et al.. (1991). Phase I study of YM 881 (zinostatin stimalamer) suspension by hepatic arterial infusion. Gan to kagaku ryōhō. 18(10). 1657–1663. 2 indexed citations

14.

Taguchi, Tetsuya, Tomohito Saito, Junko Ota, et al.. (1991). [Phase II study of YM881 (zinostatin stimalamer) suspension injected into the hepatic artery. Research Group for Intra-arterial Injection Therapy with YM881].. PubMed. 18(10). 1665–75. 8 indexed citations

15.

Nakao, I, et al.. (1990). [Combination chemotherapy of non-small cell lung cancer (NSCLC) with cisplatin (CDDP), carboquone (CQ) and prednisolone (PDN)(PPQ therapy)].. PubMed. 17(2). 217–20. 1 indexed citations

16.

Kamei, Hideo, K Takenaka, S Suga, et al.. (1986). [Phase I study of bestrabucil (KM 2210)].. PubMed. 13(6). 2208–15. 2 indexed citations

17.

Nakao, I, T Saito, Kazuhiro Kimura, et al.. (1985). [Phase I study of 5'-deoxy-5-fluorouridine (5'-DFUR)].. PubMed. 12(10). 2037–43. 2 indexed citations

18.

Nakao, I, et al.. (1979). Multidrug combination in cancer chemotherapy: MFU therapy.. The Tohoku Journal of Experimental Medicine. 129(4). 337–345. 2 indexed citations

19.

Nakao, I, et al.. (1978). Clinical Experiences with Aclacinomycin-A. PubMed. 63. 241–246. 7 indexed citations

20.

Kurokawa, Tomohiro, et al.. (1969). [Clinical experiences with PC-B-45].. PubMed. 15(12). 1056–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact